Pharmaceuticals · Pharmaceuticals: Major · NSE: ONYX · data 2026-10-30

Onyx Biotec Ltd.

₹36-1.37% on 28 OctHealth: Weak 3.3/10

Jan 2026Low ₹28.65 · High ₹48.4-10.1%

In plain words

Price: 27.5% below its 52-week high of ₹49.65.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹36

Market cap

₹65 cr

P/E

—

P/B

—

ROE

-0.4%

ROCE

0.5%

Debt / equity

0.27

Dividend yield

0.00%

1-year return

-12.4%

52-week high

₹49.65

52-week low

₹24.2

Operating margin

0.5%

Growth

Revenue (last 12 months)	₹69 cr
Net profit (last 12 months)	₹-0 cr
Sales growth, 3 years (yearly)	20.7%
Profit growth, 3 years (yearly)	—

Smart-money activity

12/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 7/20: Net +₹0.46 cr bought in bulk/block deals over 90 days; 1 net buying day, 0 net selling days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Deal

16 Sept 26Deal Bulk deal: TUSHAR KINKER bought ₹0.46 cr 0.0% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Onyx Biotec Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.27.

What is the 52-week high and low of Onyx Biotec Ltd.?

The 52-week high is ₹49.65 and the 52-week low is ₹24.2.

Similar companies

Sunil Healthcare Ltd. (SUNLOC) · Vilin Bio Med Ltd. (VILINBIO) · Zenith Drugs Ltd. (ZENITHDRUG) · Vivimed Labs Limited (VIVIMEDLAB) · Mangalam Drugs & Organics Ltd. (MANGALAM)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ONYX in NSE Scanner →